Transseptal transcatheter mitral valve-in-valve for treatment of severe mitral regurgitation in failed bioprosthesis complicated with cardiogenic shock: Case report and review of the literature. Cardiovasc Revasc Med 2018;19(7 Pt B):874-878
Date
04/11/2018Pubmed ID
29636301DOI
10.1016/j.carrev.2018.02.011Scopus ID
2-s2.0-85044930907 (requires institutional sign-in at Scopus site) 3 CitationsAbstract
Patients in cardiogenic shock due to severe failure of a mitral bioprosthesis have extremely high risk for repeat standard cardiac surgery. This patient population may benefit the most form the least invasive intervention. We report a successful transseptal mitral valve-in-valve implant performed in a patient in cardiogenic shock due to a flail mitral bioprosthesis requiring bridging intravenous inotropic and intra-aortic balloon pump support.
Author List
Rufian-Andujar S, Iftikhar O, Salinger M, Saucedo J, Feldman T, Guerrero MAuthor
Jorge Saucedo MD Chief, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Administration, IntravenousAged, 80 and over
Bioprosthesis
Cardiac Catheterization
Cardiotonic Agents
Echocardiography, Doppler, Color
Echocardiography, Transesophageal
Female
Heart Valve Prosthesis
Heart Valve Prosthesis Implantation
Hemodynamics
Humans
Intra-Aortic Balloon Pumping
Mitral Valve
Mitral Valve Insufficiency
Prosthesis Design
Prosthesis Failure
Recovery of Function
Recurrence
Shock, Cardiogenic
Treatment Outcome